[Management of neuroleptic side-effects with piracetam (author's transl)].
D000293:Adolescent; D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects*; D001480:Basal Ganglia Diseases / Q000139:chemically induced / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010889:Piracetam / Q000627:therapeutic use*; D011760:Pyrrolidinones / Q000627:therapeutic use*
D014150:Antipsychotic Agents; D011760:Pyrrolidinones; D010889:Piracetam
Ovlivnĕní nezádoucích úcinků neuroleptik piracetamen Dvojitĕ slepé placebem kontrolované srovnăní.